Preparation method of gemfibrozil crystal form I
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 浙江精进药业有限公司
- Publication Date
- 2021-09-07
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicinal chemistry, and in particular relates to a preparation method of crystal form I of gemfibrozil. Background technique
[0002] Gemfibrozil (Gemfibrozil), chemical name 2,2-dimethyl-5-(2,5-dimethylphenyloxy)-pentanoic acid, the structure is as follows:
[0003]
[0004] Gemfibrozil is a clofibrate lipid-regulating drug for the treatment of hyperlipidemia, suitable for severe type IV or V hyperlipoproteinemia, coronary heart disease, type IIb hyperlipoproteinemia and other blood lipid regulating drugs invalid.
[0005] Gemfibrozil synthesis has been reported at home and abroad with a variety of technological routes, ES545970, US3674838, CN1072823 and other documents have reported synthetic methods.
[0006] There are also literature reports on the crystal form of gemfibrozil. Patent EP0462066 reports a method for preparing an amorphous form, and CN200810162023 reports a method for preparing cry...